Hans K Hasselbalch

Hans K Hasselbalch

Clinical Professor

Member of:

  • Internal Medicine: Haematology


  1. 1996
  2. Published

    Sonographic measurement of the thymus in infants

    Hasselbalch, Hans Carl, Nielsen, Michael Bachmann, Jeppesen, Dorthe Lisbeth, Pedersen, J. F. & Karkov, J., 1996, In: European Radiology. 6, 5, p. 700-703 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2008
  4. Published

    Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence

    Lataillade, J. J., Pierre-Louis, O., Uzan, G., Jasmin, C., Martyre, M. C., Bousse-Kerdiles, M. C. L. & Hasselbalch, Hans Carl, 2008, In: Blood. 112, 8, p. 3026-3035 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. 2011
  6. Published

    High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis

    Hasselbalch, Hans Carl, Skov, V., Larsen, T. S., Thomassen, M., Riley, C. H., Jensen, M. K., Bjerrum, O. W. & Kruse, T. A., 2011, In: Leukemia Research. 35, 10, p. 1330-4 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Interferon alpha2 in the treatment of hematological malignancies. status and perspectives

    Hasselbalch, Hans Carl, 1 Jan 2011, In: Current Drug Targets. 12, 3, p. 387-391 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Interferon-alpha in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms. Status and perspectives

    Hasselbalch, Hans Carl, Larsen, T. S., Riley, C. H., Jensen, M. K. & Kiladjian, J., 1 Jan 2011, In: Current Drug Targets. 12, 3, p. 392-419 28 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European leukemiaNet

    Barbui, T., Barosi, G., Birgegard, G., Cervantes, F., Finazzi, G., Griesshammer, M., Harrison, C., Hasselbalch, H. C., Hehlmann, R., Hoffman, R., Kiladjian, J-J., Kröger, N., Mesa, R., McMullin, M. F., Pardanani, A., Passamonti, F., Vannucchi, A. M., Reiter, A., Silver, R. T., Verstovsek, S. & 1 others, Tefferi, A., 20 Feb 2011, In: Journal of Clinical Oncology. 29, 6, p. 761-770 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Interferon alfa in the treatment of philadelphia-negative chronic myeloproliferative neoplasms

    Hasselbalch, Hans Carl, Kiladjian, J. & Silver, R. T., 20 Jun 2011, In: Journal of Clinical Oncology. 29, 18

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Increase in circulating CD4CD25Foxp3 T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α

    Riley, C. H., Morten Krogh, J., Brimnes, M. K., Straten, P. T., Svane, Inge Marie, Hasselbalch, Hans Carl & Bjerrum, O. W., 25 Aug 2011, In: Blood. 118, 8, p. 2170-2173 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents

    Ghanima, W., Bussel, J. B., Junker, P., Hasselbalch, Hans Carl, Gudbrandsdottir, S., Boiocchi, L., Geyer, J. T., Orazi, A. & Feng, X., 1 Oct 2011, In: British Journal of Haematology. 155, 2, p. 248-255 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms

    Hasselbalch, Hans Carl, 1 Dec 2011, In: Expert Review of Hematology. 4, 6, p. 637-655 19 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...14 Next

ID: 2849472